[Form 4] LANTRONIX INC Insider Trading Activity

Rhea-AI Filing Summary

Lantronix (LTRX) Form 4: Director James C. Auker reported the vesting and conversion of restricted stock units into common stock and a new RSU grant. On 11/05/2025, 10,387 RSUs vested and converted into 10,387 shares of common stock at a price of $0 (Code M), leaving 10,387 common shares beneficially owned directly.

Separately, on 11/04/2025, the director received 17,081 new RSUs. The award vests one half six months after the July 23, 2025 grant date and the remaining half on the first anniversary of that date, for full vesting after one year. Following these transactions, 17,081 derivative securities (RSUs) are beneficially owned directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Auker James Chris

(Last) (First) (Middle)

C/O LANTRONIX

48 DISCOVERY, SUITE 250

(Street)

IRVINE CA 92618

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LANTRONIX INC [ LTRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/05/2025		M(1)		10,387	A	$0	10,387	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	11/05/2025		M			10,387	(3)	(3)	Common Stock	10,387	$0	0	D
Restricted Stock Units	(2)	11/04/2025		A		17,081		(4)	(4)	Common Stock	17,081	$0	17,081	D

Explanation of Responses:

1. Represent shares of common stock issued upon the vesting of restricted stock units ("RSUs") granted on July 23, 2025 (the "Grant Date").

2. RSUs convert into common stock on a one-for-one basis.

3. The restricted stock units ("RSUs") vested 100% on November 5, 2025.

4. The RSUs vest at the rate of one half (1/2) of the shares vesting six (6) months following the Grant Date and one half (1/2) of the shares vesting on the first anniversary of the Grant Date, such that the RSUs will be fully (100%) vested after one (1) year.

	Brent Stringham, Attorney-in-fact for James C. Auker	11/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Lantronix (LTRX) disclose in this Form 4?

A director reported 10,387 RSUs vesting into 10,387 common shares at $0 on 11/05/2025 and a new grant of 17,081 RSUs on 11/04/2025.

How many Lantronix (LTRX) shares were acquired from RSU vesting?

10,387 shares of common stock were issued upon RSU vesting at a price of $0.

What is the size and vesting schedule of the new RSU grant for LTRX?

17,081 RSUs, vesting 1/2 six months after the 07/23/2025 grant date and 1/2 on its first anniversary.

What is the director’s ownership after the reported transactions?

10,387 common shares directly owned and 17,081 RSUs directly beneficially owned.

Who is the reporting person and their relationship to Lantronix (LTRX)?

James C. Auker, a Director of Lantronix Inc.

What transaction code was used for the RSU conversion?

Code M was used for the RSU conversion into common stock on 11/05/2025.